Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of t...
Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature
About this item
Full title
Author / Creator
Publisher
England: Taylor & Francis Group
Journal title
Language
English
Formats
Publication information
Publisher
England: Taylor & Francis Group
Subjects
More information
Scope and Contents
Contents
Membranous nephropathy (MN), focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) are autoimmune kidney diseases and the most common causes of nephrotic syndrome. Anti-CD20 monoclonal antibodies are now recommended as first-line therapy for MN. Anti-CD20 monoclonal antibodies are also effective in steroid-dependent or frequent...
Alternative Titles
Full title
Treatment of nephrotic syndrome with anti-CD20 therapies in pregnancy: a case series and review of the literature
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_6953112d1fd24e0f8b5300cc826af4fb
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_6953112d1fd24e0f8b5300cc826af4fb
Other Identifiers
ISSN
0886-022X,1525-6049
E-ISSN
1525-6049
DOI
10.1080/0886022X.2025.2481201
